Log in

PolicyEconomic Times

OPPI DG calls for policy predictability in pharma

Positive+66

GreyOak summary

Anil Matai, OPPI DG, stated India needs predictable regulations to speed up drug approvals and boost innovation. He warned against frequent price controls under DPCO Para 19, citing China's progress in biologics. Matai emphasized shifting from generic volume to value while supporting trade margin rationalization for expensive drugs.

What it affects

  • HealthcarePositive +66

    Regulatory predictability needed for pharma innovation.Rolling sentiment Positive +32

Source

Read the original at Economic Times

More news

All news →

We use cookies

Essential cookies keep GreyOak secure and functional. Optional cookies help improve your experience and platform performance. You can update your preferences anytime.

Cookie Policy